Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMQZU9G)

Drug Name

3-(heptyloxy)benzoic acid Drug Info

Synonyms

3-(Heptyloxy)benzoic Acid; 3-(heptyloxy)benzoate; 3-heptyloxybenzoate; 3-heptyloxybenzoic acid; 3-n-Heptyloxybenzoic acid; SCHEMBL7047692; CHEMBL1161949; FOFZVIUYGPBWLV-UHFFFAOYSA-N; ZINC14980578; AKOS005288423; AS01084; DB07355

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 14368760
TTD Drug ID: DMQZU9G

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Preclinical Drug(s)

Discontinued Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Pseudomonas UDP-3-O-acyl-GlcNAc deacetylase (Pseudo lpxC)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
LpxC-1	DMV1A25	Acinetobacter baumannii infection	CA40.0Y	Preclinical	[2]
RC-01	DM4FNWO	Gram-negative bacterial infection	1B74-1G40	Terminated	[3]
MYRISTIC ACID	DMYX0BL	Discovery agent	N.A.	Investigative	[1]
Cacodylate Ion	DMK4XLD	Discovery agent	N.A.	Investigative	[4]
Palmitoleic Acid	DM4W5X8	Discovery agent	N.A.	Investigative	[4]
BB-78484	DMFBN9O	Discovery agent	N.A.	Investigative	[5]
BB-78485	DMJKA3F	Discovery agent	N.A.	Investigative	[5]
Tu-514	DMUR0TF	Discovery agent	N.A.	Investigative	[4]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Pseudomonas UDP-3-O-acyl-GlcNAc deacetylase (Pseudo lpxC)	TT0OFWN	LPXC_PSEAE	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
2	Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 2017 Jul;16(7):457-471.
3	The global preclinical antibacterial pipeline. Nat Rev Microbiol. 2020 May;18(5):275-285.
4	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
5	Antibacterial activities and characterization of novel inhibitors of LpxC. Antimicrob Agents Chemother. 2002 Jun;46(6):1793-9.